Letter comments on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single-centre prospective study: Interaction between lymphopenia and anti-SARS-CoV-2 antibodies after two injections of the Pfizer-BioNTech vaccine in patients with cancers treated by chemotherapy or immunotherapy.

Eur J Cancer

Oncology and Supportive Care Department, Foch Hospital, Suresnes, France. Electronic address:

Published: January 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552578	PMC
http://dx.doi.org/10.1016/j.ejca.2021.09.048	DOI Listing

Publication Analysis

letter comments

comments efficacy

efficacy safety

safety bnt162b2

bnt162b2 vaccination

vaccination solid

solid cancer

cancer patients

patients receiving

receiving anti-cancer

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!